Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looking to add more on the dip.!
Me too! Lower the better.!
I’m buying!
I see a gap up, a run, and 20,978,229 more reasons the gap will fill!
Correct. Same person. I’m ready for the PR and the gap up!
I’m always right
(Except when I’m not)!
Good news is imminent! - Wile E. Coyote
.158 - It closed 11/30 - .155 = $$$
$NAK. RSI is cooling. Decisions, decisions.... i feel like I should jump in on a second trade today, but am going to sit tight.
Banking on a tick up today from this level. Green trades! $IPIX!
I’m anticipating a healthy consolidation at this level. 90-95 cent target.
$30k in 27 min. Not bad! Good luck boys! $1.15
Cheers to very good day of trading! $NAK
Crazy volume. Place ur bets! Simple as it gets.
Northern Dynasty: Pebble Partnership Submits Request for Appeal to US Army Corps of Engineers $NAK
January 21, 2021 Vancouver – Northern Dynasty Minerals Ltd. (TSX: NDM; NYSE American: NAK) ("Northern Dynasty" or the "Company") reports that its 100%-owned, US-based subsidiary Pebble Limited Partnership (the “Pebble Partnership”) has formally submitted a ‘request for appeal’ (“RFA”) to the US Army Corps of Engineers (“USACE”) with respect to its recent issuance of a negative Record of Decision (“ROD”) for Alaska’s Pebble Project.
The USACE published a final Environmental Impact Statement (“EIS”) for the proposed copper-gold- molybdenum-silver-rhenium mine in July 2020, finding that Pebble would “not have measurable effects” on fish populations or fisheries in southwest Alaska. Despite this, the lead federal regulator published a ROD on November 25, 2020 denying Pebble a key permit under the Clean Water Act on the grounds that its ‘compensatory mitigation plan’ (“CMP”) is non-compliant and the project is not in the ‘public interest.’
The Pebble Partnership submitted its RFA to the USACE’s Pacific Ocean Division Engineer in Hawaii this week, in advance of the 60-day deadline following the permitting decision. The USACE has 30 days from receipt to notify the Pebble Partnership as to whether its RFA is complete. USACE guidelines indicate the administrative appeal process should conclude within 90 days, although it may be extended under certain circumstances.
Northern Dynasty believes that key aspects of the USACE’s ROD and permitting decision – including its ‘significant degradation’ finding, its ‘public interest review’ findings and its perfunctory rejection of Pebble’s CMP – are contrary to law, unprecedented in Alaska and fundamentally unsupported by the administrative record, including the Pebble Project EIS. Additional details about the Pebble Partnership’s RFA submission will be released in the days and weeks ahead.
About Northern Dynasty Minerals Ltd.
Northern Dynasty is a mineral exploration and development company based in Vancouver, Canada. Northern Dynasty's principal asset, owned through its wholly owned Alaska-based U.S. subsidiary, Pebble Limited Partnership (“PLP”), is a 100% interest in a contiguous block of 2,402 mineral claims in southwest Alaska, including the Pebble deposit, located 200 miles from Anchorage and 125 miles from Bristol Bay. PLP is the proponent of the Pebble Project, an initiative to develop one of the world's most important mineral resources.
For further details on Northern Dynasty and the Pebble Project, please visit the Company's website at www.northerndynastyminerals.com or contact Investor services at (604) 684-6365 or within North America at 1-800-667-2114. Review Canadian public filings at www.sedar.com and US public filings at www.sec.gov.
Ronald W. Thiessen President & CEO
US Media Contact:
Dan Gagnier
Gagnier Communications (646) 569-5897
https://www.northerndynastyminerals.com/site/assets/files/4886/2021-01-21-nr-ndm-ii095nvffsa.pdf
—————————
Northern Dynasty: State of Alaska to appeal Pebble Project
January 11, 2021 Vancouver – Northern Dynasty Minerals Ltd. (TSX: NDM; NYSE American: NAK) ("Northern Dynasty" or the "Company") reports the Office of Alaska State Governor Mike Dunleavy issued a statement late last week to announce his administration will formally appeal the US Army Corps of Engineers’ (“USACE”) November 25, 2020 denial of a key federal permit for Alaska’s Pebble Project.
In a statement released January 8, 2021, Governor Dunleavy said the USACE’s Record of Decision (“ROD”) and accompanying denial of a Clean Water Act 404 permit for the proposed copper-gold-molybdenum- silver-rhenium project in southwest Alaska is “flawed (and)...creates a dangerous precedent that will undoubtedly harm Alaska’s future.”
As owner of the land and subsurface mineral estate at Pebble, the State of Alaska has the right – along with Northern Dynasty’s 100%-owned US-based subsidiary Pebble Limited Partnership (“Pebble Partnership”), which owns state-issued mineral claims at the property – to launch an administrative appeal of the USACE’s permitting decision.
Northern Dynasty believes the State of Alaska – as an asset owner and professional regulator with a constitutional mandate to develop the state’s resources in the best interests of its citizens – will bring different perspectives and motivations in challenging a federal decision that Pebble believes to be arbitrary, unprecedented in Alaska and unsupported by the administrative record. This includes a serious concern about the decision’s long-term implications for Alaska’s ability to responsibly develop its natural resources.
The Pebble Partnership’s and State of Alaska’s ‘requests for appeal’ (“RFA”) must be submitted within 60 days of the USACE’s November 25, 2020 issuance of a ROD and CWA 404 permit denial. Pebble is preparing a comprehensive RFA to challenge the USACE’s permitting decision on procedural, substantive and legal grounds, including:
- that it is not supported by the administrative record for the Pebble Project, including the Environmental Impact Statement published July 24, 2020; and,
- that mitigation requirements for Pebble are contrary to policy and precedent in Alaska, and the rejection of Pebble’s Compensatory Mitigation Plan was both procedurally and substantively invalid.
In its statement, the State of Alaska also suggests the USACE’s requirements concerning mitigation at Pebble are unprecedented and inconsistent with longstanding practice and policy guidance in the state.
The Office of Alaska Governor’s statement quotes Acting Attorney General Ed Sniffen: “This appeal asks the Army Corps Pacific Ocean Division to remand the permit decision back to the Alaska District for a more thorough review consistent with the law. The Division ignored Corps’ long-standing guidance that required it to tailor mitigation requirements to recognize Alaska’s unique position of holding more intact wetlands than any of the lower 48 states combined. Instead, the Division is requiring mitigation measures that are simply impossible to meet in Alaska.”
The Pebble Partnership intends to submit its RFA to the USACE’s Pacific Ocean Division Engineer headquartered in Hawaii within two weeks. Following its receipt, the USACE will have 30 days to notify Pebble as to whether its RFA is complete. USACE guidelines indicate the administrative appeal process should conclude within 90 days.
“The Alaska District’s decision has far-reaching and ominous implications for our rights as a state to develop our resources for the benefit of all Alaskans, whether its mineral deposits like Pebble, or oil and gas on the
North Slope, or other resources anywhere in the state,” said Alaska Department of Natural Resources Commissioner Corri Feige. “The Alaska Constitution specifically directs us to develop our resources in the public interest. When a federal agency arbitrarily tries to deprive us of our rights with the stroke of a bureaucrat’s pen, we simply must challenge that action.”
About Northern Dynasty Minerals Ltd.
Northern Dynasty is a mineral exploration and development company based in Vancouver, Canada. Northern Dynasty's principal asset, owned through its wholly owned Alaska-based U.S. subsidiary, Pebble Limited Partnership (“PLP”), is a 100% interest in a contiguous block of 2,402 mineral claims in southwest Alaska, including the Pebble deposit. PLP is the proponent of the Pebble Project, an initiative to develop one of the world's most important mineral resources.
For further details on Northern Dynasty and the Pebble Project, please visit the Company's website at www.northerndynastyminerals.com or contact Investor services at (604) 684-6365 or within North America at 1-800-667-2114. Review Canadian public filings at www.sedar.com and US public filings at www.sec.gov.
Ronald W. Thiessen President & CEO
US Media Contact:
Dan Gagnier
Gagnier Communications (646) 569-5897
https://www.northerndynastyminerals.com/site/assets/files/4885/january_11-_2021-_f2.pdf
I’m sure there’s plenty more where that came from.
Green trades everyone!
Hound
Good to see an update!
Happy trading
Now what?
Alaska itself is appealing the Corps. decision now. That’s the news and the reason for the rise in market cap.
Happy new year!
LoL. We’re on the same page
Merry Christmas!
Damn. There went our hopes. How effective is that vaccine again?
Learn something every day. According to Wookieepedia the technology dates back to YT-1300 492727ZED.
Gap trigger.
yes it is.
The gap has filled for me C.
Green trades.
Hound.
O! 'tis very well—damn my blood! I shall find a time!
Have a great weekend!
Hound.
Omg best episode EVER!
I looked into participating in the trial, but couldn’t get past the penile atrophy disclaimer!
Administration of the vaccine is done in cryogenic inoculation chambers.
#filltheipixgap!
$IPIX
What confuses the shit outta me is test results observed to date on the date the company said the following included human data! Human data was the focus of the referenced PR!
I certainly was under the impression the grant application included human data until reading the 10Q.
Grant unsuccessful. We missed submission of the human data by a week??!!
—————-
[color=red][/color]Innovation Pharmaceuticals’ Brilacidin Inhibits SARS-CoV-2 (COVID-19) by 97 Percent in a Human Lung Cell Line
WAKEFIELD, MA – June 17, 2020 (GLOBE NEWSWIRE) Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, reports today receiving data from ongoing laboratory testing being conducted at a U.S. Regional Biocontainment Laboratory (RBL)............ Brilacidin has now demonstrated potent inhibition of SARS-CoV-2 in human lung and kidney cell lines, and in VERO cells, in laboratory testing conducted by independent academic researchers at two institutions........Testing results observed to date formed the basis for a federal grant application that was submitted last week by the RBL, in collaboration with the Company, proposing to evaluate Brilacidin’s potential as a pan-coronavirus therapeutic, with possible extension into other viruses. The Company is in the process of manufacturing Brilacidin for intravenous (IV) dosing and will be seeking FDA guidance for a planned COVID-19 clinical study.
https://www.sec.gov/Archives/edgar/data/1355250/000147793220003469/ipix_ex991.htm
10-Q For the quarterly period ended: September 30, 2020
The Company is collaborating with a Regional Biocontainment Laboratory (RBL) for federal grants to fund continued research on Brilacidin as a treatment for SARS-CoV2. An earlier grant application was unsuccessful. At the time of that grant filing deadline, the only research data available was limited to non-human Vero cells. Subsequent to the filing, human cell line experiments were completed and the data is now available. Additional grant applications incorporating the new data are planned for submission before the end of 2020.
https://www.sec.gov/Archives/edgar/data/1355250/000147793220006561/ipix_10q.htm
US based companies conducting foreign trials under an IND is common practice. Combining US AND Non-US enrollment for any given study isn’t nearly as common. What makes you think the trial will take place in the US? Just a guess?